These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6361783

  • 1. Measurement of human venous plasma prostacyclin and metabolites by radioimmunoassay: a reappraisal.
    Forder RA, Carey F.
    Prostaglandins Leukot Med; 1983 Nov; 12(3):323-46. PubMed ID: 6361783
    [Abstract] [Full Text] [Related]

  • 2. Prostacyclin and thromboxane in non-insulin dependent diabetes: the chlorpropamide alcohol flush reaction revisited.
    Johnston C, Carey F, Forder RA, Haworth D.
    Clin Sci (Lond); 1984 Dec; 67(6):633-8. PubMed ID: 6548428
    [Abstract] [Full Text] [Related]

  • 3. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
    Ritter JM.
    Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
    [Abstract] [Full Text] [Related]

  • 4. Rapid and effective conversion of 6-keto-prostaglandin F1 alpha to 6,15-diketo-13, 14-dihydro-prostaglandin F1 alpha-immunoreactive material in vivo.
    Förstermann U, Neufang B, Hertting G.
    Prostaglandins Leukot Med; 1982 Sep; 9(3):277-84. PubMed ID: 6752956
    [Abstract] [Full Text] [Related]

  • 5. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion.
    Ylikorkala D, Viinikka L.
    Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068
    [Abstract] [Full Text] [Related]

  • 6. Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
    Hensby CN, Fitzgerald GA, Friedman LA, Lewis PJ, Dollery CT.
    Prostaglandins; 1979 Nov; 18(5):731-6. PubMed ID: 396578
    [Abstract] [Full Text] [Related]

  • 7. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma.
    Siess W, Dray F.
    J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588
    [Abstract] [Full Text] [Related]

  • 8. Measurement of 13,14-dihydro-6,15-dioxo PGF1 alpha by radioimmunoassay: application to the study of prostacyclin metabolism.
    Myatt L, Jogee M, Lewis PJ, Elder MG.
    Prog Lipid Res; 1981 Mar; 20():807-10. PubMed ID: 7043488
    [No Abstract] [Full Text] [Related]

  • 9. Prostacyclin in the circulation of patients with vascular disorders undergoing surgery.
    Ritter JM, Hamilton G, Barrow SE, Heavey DJ, Hickling NE, Taylor KM, Hobbs KE, Dollery CT.
    Clin Sci (Lond); 1986 Dec; 71(6):743-7. PubMed ID: 3539459
    [Abstract] [Full Text] [Related]

  • 10. Different results of plasma 6-keto-prostaglandin F1 alpha measurements utilizing two antisera with apparently similar specificity.
    Viinikka L, Ylikorkala O.
    Prostaglandins Leukot Med; 1982 Jul; 9(1):1-7. PubMed ID: 6957891
    [Abstract] [Full Text] [Related]

  • 11. Prostacyclin concentrations in cord blood and in the newborn.
    Jacqz EM, Barrow SE, Dollery CT.
    Pediatrics; 1985 Dec; 76(6):954-7. PubMed ID: 3906549
    [Abstract] [Full Text] [Related]

  • 12. Increased plasma levels of 6-oxo-prostaglandin F1 alpha, a stable metabolite of prostacyclin, in acute kidney transplant rejection.
    Leithner C, Sinzinger H, Peskar BA.
    Prostaglandins Med; 1981 Jul; 7(1):15-8. PubMed ID: 7025069
    [Abstract] [Full Text] [Related]

  • 13. Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs.
    Salmon JA, Mullane KM, Dusting GJ, Moncada S, Vane JR.
    J Pharm Pharmacol; 1979 Aug; 31(8):529-32. PubMed ID: 39993
    [Abstract] [Full Text] [Related]

  • 14. A radioimmunoassay for 6-keto-prostaglandin F1 alpha utilizing an antiserum against 6-methoxime-prostaglandin F1 alpha. Application to study renal in vitro synthesis of prostacyclin.
    Oliw E.
    Prostaglandins; 1980 Feb; 19(2):271-84. PubMed ID: 6992225
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of vascular prostacyclin (PGI2) production by human serum.
    Ritter JM, Orchard MA, Lewis PJ.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3047-50. PubMed ID: 6756409
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the quantitative analysis of 6-oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry and radioimmunoassay.
    Hensby CN, Jogee M, Elder MG, Myatt L.
    Biomed Mass Spectrom; 1981 Mar 01; 8(3):111-7. PubMed ID: 6894556
    [Abstract] [Full Text] [Related]

  • 17. Formation of prostanoids during intravascular complement activation in the rabbit.
    Bult H, Herman AG, Laekeman GM, Rampart M.
    Br J Pharmacol; 1985 Feb 01; 84(2):329-36. PubMed ID: 3884074
    [Abstract] [Full Text] [Related]

  • 18. Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancer.
    Polterauer P, Sinzinger H, Peskar BA.
    Prostaglandins Leukot Med; 1986 Jun 01; 22(3):249-58. PubMed ID: 3523543
    [Abstract] [Full Text] [Related]

  • 19. 6-keto-PGF1 alpha levels and prostacyclin therapy in 2 adult patients with hemolytic-uremic syndrome.
    Hautekeete ML, Nagler JM, Cuykens JJ, Parizel G, Laekeman GM, Herman AG.
    Clin Nephrol; 1986 Sep 01; 26(3):157-9. PubMed ID: 3533335
    [Abstract] [Full Text] [Related]

  • 20. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma.
    Machleidt C, Förstermann U, Anhut H, Hertting G.
    Eur J Pharmacol; 1981 Aug 27; 74(1):19-26. PubMed ID: 7032951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.